Cadrenal Therapeutics, Inc. (CVKD): Nasdaq/NYSE listing notice — Cadrenal Therapeutics receives Nasdaq minimum bid price deficiency notice

Cadrenal Therapeutics, Inc.

Nasdaq notice on Sept 6, 2023, for bid price below $1.00 for 30 consecutive days.
Company has 180 calendar days until March 4, 2024, to regain compliance.
To comply, closing bid price must be at least $1.00 for 10 consecutive business days.
Company may consider options including reverse stock split to regain compliance.
Delisting not immediate; subject to remaining listing requirements.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cadrenal Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

September 6, 2023, Cadrenal Therapeutics, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”), requiring listed securities to maintain a minimum bid price of $1.00 per share because the Company’s closing bid price for the last 30 consecutive business days was below $1.00 per share. The notification received has no immediate effect on the Company’s continued listing on the Nasdaq Capital Market, subject to the Company’s compliance with the other continued listing requiremen

View on SEC.gov

Browse all listing & compliance notices →

Cadrenal Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-075392

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.